Spinal Muscular Atrophy Outcome Measures Workshop (English Language)
Earlier this year, NMD4C, MDC and Quebec SMA Network hosted the first interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal Muscular Atrophy (SMA).
To complement this training session, the NMD4C will be hosting an English-language interactive training workshop on standardizing assessment practices in SMA outcome measures.
This workshop will be taking place the day before the Allied Professionals Forum in Montreal.
Please ensure you register before the deadline of June 18th, 2024.
Please ensure that you meet the eligibility criteria:
- Must be a physiotherapist or occupational therapist at a Canadian institution/clinic evaluating patients of any age with SMA.
- Must be a NMD4C member.
Disclaimer:
We have a limited number of seats available for this workshop (in-person only). Participants will be selected based on considerations related to geography, case load and clinic needs. There is a discounted hotel room rate as part of the Allied Professionals Forum meeting and financial support for travel and accommodations will be provided (details to follow upon acceptance).
Read next...
King’s Medal Awarded to Canadian Neuromuscular Clinicans and Researchers
Several NMD4C investigators and collaborators from the Canadian neuromuscular community have been awarded a King Charles III’s Coronation Medal in recognition of their outstanding contributions and service.
New Home on NMD4C Website for Community of Practice
Check out the new home for the NMD4C community of practice (CoP), now live on the NMD4C website!
New NMD4C Collaborative Research Training Awards Launching May 2025
The NMD4C is excited to announce a new program for neuromuscular research trainees that will support collaboration opportunities between Canadian research labs.
Neuromuscular Research Grant Competitions from Defeat Duchenne Canada and Myotonic Dystrophy Foundation You Can Apply For Today!
Applications are open for Defeat Duchenne Canada’s research grant cycle, and Myotonic Dystrophy Canada’s fellowship and scholar grant programs.
